Day One Biopharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Day One Biopharmaceuticals

10/08/2021 22:52

* Day One Biopharmaceuticals Inc  DAWN.OQ  reported a quarterly
adjusted loss of $5.04​​ per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of 31 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Day One Biopharmaceuticals Inc's reported EPS for the quarter
was a loss of $5.04​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Day One Biopharmaceuticals Inc shares had risen by 16.6% this
quarter.
* The company reported a quarterly loss of $114.28 million.
* Wall Street's median 12-month price target for Day One
Biopharmaceuticals Inc is $32.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 10 at 09:52 p.m.  ​All
figures in US dollars unless otherwise stated